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Abstract
Background: An IFN-c response to M. tuberculosis-specific antigens is an effective biomarker for M. tuberculosis infection but
it cannot discriminate between latent TB infection and active TB disease. Combining a number of cytokine/chemokine
responses to M. tuberculosis antigens may enable differentiation of latent TB from active disease.
Methods: Asymptomatic recently-exposed individuals (spouses of TB patients) were recruited and tuberculin skin tested,
bled and followed-up for two years. Culture supernatants, from a six-day culture of diluted whole blood samples stimulated
with M. tuberculosis-derived PPD or ESAT-6, were measured for IFN-c, IL-10, IL-13, IL-17, TNF-a and CXCL10 using cytokine
ELISAs. In addition, 15 patients with sputum smear-positive pulmonary TB were recruited and tested.
Results: Spouses with positive IFN-c responses to M. tuberculosis ESAT-6 (.62.5 pg/mL) and TB patients showed high
production of IL-17, CXCL10 and TNF-a. Higher production of IL-10 and IL-17 in response to ESAT-6 was observed in the
spouses compared with TB patients while the ratios of IFN-c/IL-10 and IFN-c/IL-17 in response to M. tuberculosis-derived
PPD were significantly higher in TB patients compared with the spouses. Tuberculin skin test results did not correlate with
cytokine responses.
Conclusions: CXCL10 and TNF-a may be used as adjunct markers alongside an IFN-c release assay to diagnose M.
tuberculosis infection, and IL-17 and IL-10 production may differentiate individuals with LTBI from active TB.
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Introduction
Tuberculosis (TB) remains a global health problem with
approximately one third of the world population thought to be
infected with M. tuberculosis (M. tb) [1]. Among infected individuals,
only about 10% progress to active disease and the remaining 90%
maintain a latent TB infection (LTBI) without clinical TB
symptoms [2]. These individuals with LTBI can remain healthy
for decades or, in an unknown proportion, resolve infection
spontaneously but have a significantly elevated risk of developing
TB during their life time. Therefore, a major challenge of TB
control includes diagnosis and treatment of latently-infected
individuals who may act as a reservoir for new TB cases,
particularly in areas where TB is endemic.
The IGRA (IFN-c release assay) using the immune response to
the M. tb virulence factors, early secreted antigen target, 6 kDa
(ESAT-6) and culture filtrate protein, 10 kDa (CFP-10) to
diagnose M. tb infection has been developed to overcome the
drawback of the tuberculin skin test which includes false positive
reactions due to cross-reactivity between tuberculin and antigens
from environmental mycobacteria and BCG [3]. However, despite
the specificity of these antigens, IGRA does not distinguish
between latent TB infection and active TB disease [4]. Thus, there
is an urgent need to identify better immunological biomarkers of
TB infection and disease status.
Transmission of TB from household contacts has been
identified as an important source of infection in Malawi [5]. An
epidemiological study by the Karonga Prevention Study (KPS) in
rural Malawi showing that 5% of adult TB cases reported their
spouses with previous smear positive TB [6] indicates that spouses
of TB patients are at particularly high risk of M. tb infection and
disease, presumably by virtue of intensive intimate exposure to TB
patients through daily contact and nursing. The prevalence of
tuberculin skin test (TST) ‘‘positivity’’ was higher in the recruited
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spouses of TB patients than in community controls using two cut-
offs ($10 and $15 mm of indurations) [7], as was the median size
of TST induration. The high rate of TST positivity and
conversion in spouses compared with community controls
confirms that the spouses of TB patients are a high risk group
for M. tb infection.
The current study was therefore designed to look at cytokine
responses to a panel of mycobacterial antigens including M. tb
ESAT-6 and M. tb-derived purified protein derivative (PPD) in the
same cohort of 148 spouses of TB patients, using a previously-
described whole blood assay (WBA) [8]. We hypothesized that the
individuals with presumed recent M. tb infection who remained
healthy, must have a state (of uncertain duration) analogous to
protective immunity against the pathogen as they have not rapidly
progressed to disease and would therefore have different cytokine
and chemokine responses to M. tb antigens compared to TB
patients. We performed IFN-c ELISAs in the spouses without TB
and HIV infection, and in addition, determined the production of
the cytokines; IL-10, IL-13, IL-17, CXCL10/IP-10 and TNF-a in
response to PPD and ESAT-6 antigens. These responses were
compared to those in 15 patients with sputum smear-positive
pulmonary TB.
Materials and Methods
Prospective recruitment of spouses of index TB patients
The spouses selected as TB contacts for this study were a sub
group derived from a large cohort recruited for an epidemiological
study for which sputum smears, cultures and immunological assays
were conducted at KPS [7]. From November 2002 to July 2005,
smear positive TB patients were asked about co-residence with any
spouse since onset of cough and their spouses were recruited six
weeks after the index case started treatment by direct contact on
the TB ward or by visiting the household. Eligibility of spouses was
verified and outcome details of the index case were collected.
Informed written consent was obtained for interview and all tests;
TST (Mantoux method with 2 IU intradermal RT23), HIV
counselling and testing, syphilis and pregnancy testing, CD4
count, clinical examination and blood sampling for immunological
testing. Spouses were invited to attend the hospital for clinical
review and chest X-ray to exclude active TB. Those presenting
with persistent cough provided a sputum sample for testing [7].
Amongst the 148 recruited spouses, 143 spouses had no active TB
at baseline and 89 were HIV negative. The spouses were followed
up at 6, 12 and 24 months after the baseline date with TST and
blood collection to examine the IFN-c immune responses to M. tb
antigens such as PPD and ESAT-6. None of the spouses without
TB at baseline developed TB during the two years of active follow-
up [7]. However, 7 spouses are known to have progressed to active
TB in the subsequent period [7].
Ethical permission for this study to look at the risk of infection
and disease progression in spouses of TB patients was granted by
the National Health Science Research Committee (NHSRC) in
Malawi (#01138) and the ethics committee of the London School
of Hygiene & Tropical Medicine (LSHTM) (#745a) [6].
Diluted WBA and IFN-c ELISA
A WBA and quantitative IFN-c ELISA were performed as
previously described [8]. Briefly, heparinized blood was diluted by
1 in 5, with RPMI 1640 supplemented with penicillin and
streptomycin plus 2 mM L-glutamine (Gibco BRL, Paiseley, UK).
A total of 100 mL was added into each well with 100 mL of each
PPD (RT49; Lot204; Statens Serum Institute (SSI), Copenhagen,
Denmark] at a final concentration of 5 mg/mL, ESAT-6 (SSI) at a
final concentration of 10 mg/mL, or PHA (149781KA; Difco
Laboratories, Oxford, UK) at a final concentration of 5 mg/mL
and RPMI 1640 supplemented with 2 mM L-glutamine (Gibco
BRL). After a 6-day incubation at 37uC, the culture supernatant
was harvested and the production of IFN-c was measured in
culture supernatant using commercial antibody pairs (Pharmin-
gen, San Diego, California) [8]. Recombinant IFN-c (Pharmingen)
was used for the standard curve with a range of 31 – 2000 pg/mL
and a ‘‘positive’’ IFN-c response was defined as.62.5 pg/mL [8].
Collection of spouse samples for other cytokine ELISAs
The culture supernatant samples obtained from the prospec-
tively recruited spouses [7] have been stored at 280uC for 4 years
since the WBA and IFN-c ELISA were carried out. Samples from
spouses with HIV were excluded from this study and 150 archived
samples at all of the follow-up stages as well as the baseline were
collected for further research. These 150 archived culture
supernatant samples are composed of the samples obtained from
40 subjects at baseline, 49 at 6 months, 39 at 12 months and 22 at
24 months follow-up. Some of the samples were unavailable at
baseline or follow-up as those were previously used up for other
assays. Due to the limitation of the samples which were available
from the same subjects, we performed our study focusing on the
groups at baseline and each follow-up rather than on individual
follow-up. The subjects consists of 33% of males and 67% of
females aged 40 on average. The archived samples include one
control cultured with RPMI medium only and 3 stimulated
supernatants i.e. PPD, ESAT-6 and PHA from each individual
resulting in a total of 600 culture supernatant samples that were
available to test in this study.
Recruitment of Malawian TB patients and IFN-c ELISA
TB patients aged between 18 and 50 years were recruited (mean
age: 41, 40% males and 60% females), at diagnosis or within the
first three months of treatment, and used as TB disease controls.
HIV positive individuals, anyone on steroids or chemotherapy and
those who had any form of cancer or diabetes were excluded. Any
special population i.e. pregnant women, prisoners, and mentally
and physically disabled subjects were also excluded from this
study. Information sheets, including those translated into local
languages, were prepared for TB patients at Karonga District
Hospital and Chilumba Rural Hospital in Malawi. The study was
explained to the patients and written consents were obtained from
all of the study participants. Study samples and questionnaires
were identified by a unique blood number and study number for
confidentiality in a specimen form. Ethical permission for 15 TB
patients was granted by the LSHTM ethics committee (#5929)
and NHSRC in Malawi (#866) after the review of ethics
application forms including research proposal, consent forms
and information sheets.
The diluted WBA for TB patients was performed as previously
described [8] using PPD (RT50; Lot219; SSI) at a final
concentration of 5 mg/mL, ESAT-6/CFP-10 [9–10, Bill and
Melinda Gates Foundation Grand Challenge 6 (BMGF GC6)
project; batch 040101] at a final concentration of 10 mg/mL, PHA
(Lot017k4029; Sigma-Aldrich) at a final concentration of 5 mg/mL
and RPMI 1640 supplemented with 1% L-glutamine (Sigma-
Aldrich). After a 6-day incubation at 37uC, the culture supernatant
was harvested and the production of IFN-c was measured in
culture supernatant. The IFN-c ELISA protocol was slightly
modified using the standard sigmoid curve for TB patients [11].
Immune Responses in Close TB Contacts and Patients
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Cytokine ELISAs in the samples of spouses and TB
patients
A total of 150 samples were selected for 5 different cytokine
ELISAs and each sample included cultures stimulated with, PPD
or ESAT-6 and PHA and RPMI-only controls which were used
for whole blood assays with 6-day incubation. Thus, 4 culture
supernatant samples obtained from each of 150 spouses (n = 600)
were used for these ELISAs, and 56 samples were used for a
comparison test to confirm the results between the plates using
different volumes of samples, standards and positive controls. To
control for interplate and intraplate variation, the positive controls
for each cytokine ELISA were prepared with culture supernatant
stimulated with PHA for IL-10, IL-13, IL-17, CXCL10, and LPS
for TNF-a.
These samples had limited volumes for the further assays, and a
multiple transfer technique of the samples was applied for the 5
cytokine ELISAs. Samples were loaded on the IL-13 plate first and
transferred to IL-10, CXCL10, IL-17 and TNF-a plates in turn
according to the expected limit of detection for each assay (from
lowest to highest). The volume of samples transferred started at
100 mL for IL-13, 95 mL for IL-10, 90 mL for CXCL10, 85 mL for
IL-17 and 80 mL for TNF-a. The volume of standard and positive
control followed the same volumes of samples for each different
cytokine ELISA. The ELISAs for IL-10, IL-13, IL-17, TNF-a and
CXCL-10 were performed using the kits purchased from R & D
Systems (DuoSet ELISA Development System). The positive
responses were defined as values which are twice the limit of
detection of the assays in order to minimize false positive
responses; .31 pg/mL for IL-17 and TNF-a, .62.5 pg/mL for
IL-10 and CXCL10, and .188 pg/mL for IL-13.
Statistical analysis
Spearman’s rank correlation coefficient was calculated to
measure the association of cytokine responses between intact
(untransferred) and transferred samples in 5 different cytokine
ELISAs and the correlation between TST induration size and
cytokine responses. The difference of median responses of cytokine
production among three groups depending on the IFN-c responses
to ESAT-6 in spouses and TB patients were analysed by one way
ANOVA and Dunn’s multiple comparison tests.
Results
Comparison of cytokine responses between intact and
transferred samples
Due to limited sample volumes for the cytokine ELISAs, culture
supernatant samples were transferred sequentially from one
cytokine ELISA plate to another cytokine ELISA plate. IL-13
was the first cytokine tested in the sequence, and simply received
untreated supernatant. However, although ELISA capture should
be specific for the cytokine to be tested, there is the possibility that
the ELISA results could be affected by non-specific protein loss (for
example by adsorption). Therefore, all of the subsequent ELISAs
where supernatant was transferred (IL-10, IL-17, TNF-a and
CXCL10) were compared using 56 culture supernatant samples to
test the influence of transferring samples on cytokine responses.
Spearman’s rank correlation coefficients were above 0.9 (P,0.001)
in all of the cytokine responses, indicating that there is a very
strong association of the cytokine responses when comparing
transferred samples or sample used directly on one plate. This
indicates that the multiple transfer of samples from one assay plate
to the next did not affect the interpretation of the results (Figure
S1).
Distribution of cytokine responders at baseline and
follow-up in spouses
The proportion of individuals producing IFN-c, IL-13, IL-10,
CXCL10, IL-17 and TNF-a upon ESAT-6 (Figure 1) and PPD
(Figure 2) stimulation was analysed at baseline and follow-up.
There were no significant changes in proportions of IFN-c
responders to ESAT-6 and PPD in the spouses who were
prospectively recruited at baseline and follow-up time points
[12]. In this study, the distribution of IFN-c responders was
reanalysed in HIV-negative subjects who were involved in the
analysis of additional cytokines: 40 subjects at baseline, 49 at 6
months, 39 at 12 months and 22 at 24 months follow-up. In
response to ESAT-6, 16 of 40 spouses showed positive IFN-c
responses (.62.5 pg/mL) at baseline (Figure 1A) while 35 of the
40 spouses showed positive IFN-c responses to PPD (Figure 2A).
Although the proportion of the responders showing a higher level
of IFN-c production (.500 pg/mL) to PPD was increased at 24
months (19/22) compared to baseline (25/40), there were no
significant differences of the proportions of responders at 24
months in response to PPD and ESAT-6 (P.0.05, Figure 2A and
1A). The magnitude of IFN-c responses to ESAT-6 was not
significantly changed from the baseline to each follow-up time
point while the median value of IFN-c in response to PPD
gradually increased (from 517 to 4000 pg/mL) after 6 months
follow- up (data not shown).
All of the spouses showed positive TNF-a responses (.31 pg/
mL) to ESAT-6 at baseline and the proportion of responders who
produced high levels of TNF-a (.250 pg/mL) declined according
to the follow-up time (Figure 1F). In contrast, most of the spouses
did not produce IL-13 at baseline and follow-up time points
(,188 pg/mL) (Figure 1B). The percentage of IL-10 responders
(.62.5 pg/mL) was 27.5% (11/40) at baseline but the proportion
gradually decreased to 5.1% (2/39) (P,0.05) and 0% (P,0.01) at
12 and 24 months follow-up respectively (Figure 1C). The
proportion of CXCL10 responders to ESAT-6 (.62.5 pg/mL)
was 40% at baseline but there was no significant difference of the
proportion throughout the follow-up stages (P.0.05, Figure 1D).
The percentage of IL-17 responders (.31 pg/mL) was 27.5%
(11/40) at baseline and the proportion was slightly decreased to
18.4% (9/49) and 17.9% (7/39) at each 6 and 12 month time
point (P.0.05, Figure 1E). In response to PPD, the majority of the
spouses tested showed CXCL10 (40/40), IL-17 (29/40) and TNF-
a responses but only 3 of 40 spouses showed IL-13 and IL-10
responses at baseline (Figure 2). There were no significant
differences in the patterns of CXCL10 and TNF-a production
throughout the follow-up period (P.0.05, Figure 2).
Immune responses based on IFN-c responses to ESAT-6
The spouses were divided into two groups based on the IFN-c
responses to ESAT-6 and 48 spouses showing positive IFN-c
responses (.62.5 pg/mL and designated ‘‘S2’’) were considered to
be those who were most likely to have LTBI compared with 102
spouses with negative IFN-c responses (,62.5 pg/mL, designated
‘‘S1’’). The cytokine responses including IL-13, IL-10, CXCL10,
IL-17 and TNF-a in response to ESAT-6, PPD or PHA were
compared among the S1 spouses, the S2 spouses and TB patients.
As would be predicted, median production of IFN-c and CXCL10
in response to ESAT-6 was significantly higher in the S2 spouses
compared with the S1 group (P,0.001). However, these cytokine
responses did not differentiate between the S2 contacts and
patients (Figure 3A) who both produced significantly more IFN-c
and CXCL10 than the S1 spousal contacts (P,0.001). However,
production of IL-10 was significantly higher only in the S2 spouses
compared with both TB patients and S1 contacts (P,0.05,
Immune Responses in Close TB Contacts and Patients
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Figure 3A). IL-17 production was also higher in response to
ESAT-6 in the S2 spouses compared to the other groups with or
without significance (P,0.001; S1, P.0.05; TB, Figure 3A). IL-13
production in response to ESAT-6 was not significantly different
between any of the groups, and although the spouses had higher
levels of IL-10 than the TB patients, this was only significant for
the S2 spouse group (Figure 3A). In response to PPD, IFN-c, IL-17
and TNF-a production were all significantly higher in both S2
spouses and TB patients compared with those with negative IFN-c
responses to ESAT-6 while none of the cytokines tested
Figure 1. The proportion of cytokine responders to ESAT-6 at baseline and follow-up time points. The proportion of responders
producing IFN-c (A), IL-13 (B), IL-10 (C), CXCL10 (D), IL-17 (E) and TNF-a (F) in response to ESAT-6 was analysed in 40 spouses at baseline, 49 at 6
months, 39 at 12 months and 22 at 24 months follow-up. There were no significant differences in the proportions of IFN-c responders between
baseline and 24 months follow-up. Most of spouses did not produce IL-13 in responses to ESAT-6 at baseline, and this did not change over the 24
months follow-up. The proportions of IL-10 and TNF-a responders to ESAT-6 gradually declined at 6, 12 and 24 months.
doi:10.1371/journal.pone.0079742.g001
Immune Responses in Close TB Contacts and Patients
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differentiated between the S2 and TB groups (Figure 3B). All
cytokines were highly produced in response to PHA, suggesting no
effect of non-specific immunosuppression on cytokine responses to
ESAT-6 and PPD (Figure 3C).
Analysis of immune responses by the ratio of cytokine
responses
Since cytokines can modulate each other’s effects and are rarely
produced in isolation, the cytokine responses to ESAT-6 and PPD
were further analysed by the ratio of cytokine responses between
the groups of spouses and TB patients. This is particularly
Figure 2. The proportion of cytokine responders to PPD at baseline and follow-up time points. The proportion of responders producing
IFN-c (A), IL-13 (B), IL-10 (C), CXCL10 (D), IL-17 (E) and TNF-a (F) in response to PPD was analysed in 40 spouses at baseline, 49 at 6 months, 39 at 12
months and 22 at 24 months follow-up. The majority of the spouses did not produce IL-13 and IL-10 in response to PPD at baseline or 24 months
later while high levels of IFN-c, CXCL10, IL-17 and TNF-a were detected. There were no significant changes in the proportions of cytokine responders
throughout the follow-up period.
doi:10.1371/journal.pone.0079742.g002
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important when looking at the production of pro- and anti-
inflammatory cytokines. The ratio of IFN-c/IL-10, CXCL10/IL-
10, IFN-c/IL-17, CXCL10/IL-17 and IL-17/IL-10 in response to
ESAT-6 was significantly higher in both S2 spouses and TB
patients compared with the S1 contact group (Figure 4A). The
ratio of TNF-a/IL-10 was also significantly higher in TB patients
than in the S1 group (P,0.01) while none of the ratios in cytokine
responses to ESAT-6 differentiated between S2 contacts and TB
patients (Figure 4A). On the other hand, the ratio of IFN-c/IL-10
and IFN-c/IL-17 in responses to PPD discriminated the TB
patient group from the S2 spouses with significantly higher
responses in TB patients (P,0.01) (Figure 4B). The median ratio
of IFN-c/IL-10 response in S2 spouses and TB patients was 165
and 338 respectively, and 0.45 and 2.2 for IFN-c/IL-17 in each
group.
TST induration in spouses and association between TST
size and immune responses
Those individuals who have TST induration of more than 10
and 15 mm are generally assumed to be infected with M. tb. The
information on TST induration size was obtained for 34 spouses at
baseline, 37 spouses at 6 months, 22 spouses at 12 months and 10
spouses at 24 months follow-up time point. The majority of
spouses already had TST induration of more than 10 mm at
baseline (Figure 5A). The proportion of spouses with a TST
response greater than 10 mm increased according to the follow-up
Figure 3. Cytokine responses in spouses and TB patients. The cytokine responses to ESAT-6 (A), PPD (B) and PHA (C) were analysed in the
spouses who showed negative IFN-c responses to ESAT-6 (,62.5 pg/mL, n = 102; indicated as S1), the spouses with positive IFN-c responses
(.62.5 pg/mL, n = 48; indicated as S2) and TB patients (n = 15; indicated as T). The S2 contacts and TB patients showed significantly higher
production of CXCL10, IL-17 and TNF-a production in response to ESAT-6 compared with the S1 contacts. In response to PPD, IL-17 and TNF-a
production was also significantly higher in the 2 groups compared with the group of S1. However, only IL-10 and IL-17 differentiated the S2 spouses
from TB patients by showing higher production in the S2 group than TB patients. In response to PHA, all cytokines were highly detected in 3 groups.
Median responses are marked with horizontal bars. (* P,0.05, ** P,0.01, *** P,0.001)
doi:10.1371/journal.pone.0079742.g003
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time while the proportion of those with below 10 mm of TST
induration decreased (Figure 5A). At 24 months follow-up, none of
the subjects showed ,10 mm of TST induration while .15 mm
of TST induration was found in 80% of spouses (Figure 5A).
However, there was no significant difference in median responses
to ESAT-6 in any of the cytokines tested between the groups of
,10 mm and .15 mm, and none of the cytokine responses to
PPD differed by the TST induration size of the spouse (data not
shown). To determine the association between TST induration
size and the cytokine responses to M. tb antigens, the TST
induration sizes and cytokine responses from 101 spouses at all of
the follow-up time points as well as baseline were analysed by
Spearman’s rank correlation test. The TST induration size did not
correlate with the magnitude of the cytokine responses to either
ESAT-6 or PPD stimulation (Figure 5B and 5C).
Discussion
In this study, we examined a combination of cytokine and
chemokine responses based on IFN-c responses to ESAT-6 in
spouses and TB patients in order to find potential markers which
may differentiate the high risk group for M. tb infection from active
TB patients. Our results showed that IL-10 production in response
to ESAT-6 was significantly higher in ESAT-6 responder spouses
(S2) than TB patients (P,0.05), and IL-17 was also highly detected
in spouses (S2) compared with TB patients. In response to PPD,
the ratio of IFN-c/IL-10 and IFN-c/IL17 were significantly lower
in spouses (S2) than TB patients (P,0.01), suggesting that IL-10
and IL-17 may help to differentiate between LTBI and TB
patients in addition to use of IGRA.
Many studies have been undertaken to identify alternative
markers for LTBI, as current diagnostic tests such as IGRA to
measure IFN-c cannot distinguish between LTBI and active
disease [13]. CXCL10 is one of the candidate markers which have
been suggested to distinguish the individuals with LTBI or TB
patients from uninfected controls [14] and ESAT-6 induced
CXCL10 production was superior to IFN-c in both specificity and
sensitivity for detecting LTBI in rheumatoid arthritis patients who
received anti-TNF-a treatment [15]. The observation of signifi-
cantly higher CXCL10 production in response to ESAT-6 in
spouses (S2) and TB patients compared with spouses showing
negative IFN-c responses to ESAT-6 (S1) in this study supports the
previous findings that CXCL10 may be an adjunct marker for
Figure 4. The ratio of cytokine responses in spouses and TB patients. The ratio of cytokine responses to ESAT-6 (A) and PPD (B) were
analysed in the spouses who showed negative IFN-c responses to ESAT-6 (,62.5 pg/mL, n = 102; indicated as S1), the spouses with positive IFN-c
responses (.62.5 pg/mL, n = 48; indicated as S2) and TB patients (n = 15; indicated as T). The ratio of IFN-c/IL-10, CXCL10/IL-10, TNF-a/IL-17, IFN-c/IL-
17 and IL-17/IL-10 differentiated the S2 and TB groups from S1 in responses to both ESAT-6 and PPD. None of the ratios differentiated between the S2
and T groups upon ESAT-6 stimulation while IFN-c/IL-10 and IFN-c/IL-17 in response to PPD distinguished S2 from TB patients. Median ratio of
cytokine responses is marked with horizontal bars. (* P,0.05, ** P,0.01, *** P,0.001)
doi:10.1371/journal.pone.0079742.g004
Immune Responses in Close TB Contacts and Patients
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Figure 5. TST indurations and association between TST size and cytokine responses. A. TST sizes were obtained from 34 spouses at
baseline, 37 spouses at 6 months, 22 spouses at 12 months and 10 spouses at 24 months follow-up time point. More than 75% of spouses already
had above 10 mm of TST induration at baseline. The proportion of those who had more than 10 or 15 mm of TST induration was increased according
to the follow-up time while the proportion of those with below 10 mm of TST induration was decreased. None of the subjects showed a TST
induration below 10 mm at the 24 months follow-up but about 80% of these had more than 15 mm of TST induration. B–C. None of the cytokine
production in response to ESAT-6 (B) and PPD (C) was correlated with TST size in 101 spouses by Spearman’s rank correlation test. Spearman’s rank
correlation coefficients (r) and P values are indicated in each graph.
doi:10.1371/journal.pone.0079742.g005
Immune Responses in Close TB Contacts and Patients
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detecting infection alongside with IFN-c although in this cohort, it
could not differentiate TB contacts from TB patients.
In mice, IL-10 may play a role in disease progression. Bacterial
burden was reduced in M. tb-infected CBA mice with decreased
IL-10 expression while the mice expressing high levels of IL-10
failed to control bacteria [16]. However, in humans, lower levels of
IL-10 and IL-13 have been detected in TB cases compared with
contacts following PPD stimulation overnight [17]. Our study
showed that levels of IL-10 and IL-13 production to PPD were not
different between the spouses showing positive IFN-c responses to
ESAT-6 (.62.5 pg/mL, indicated as S2 in Figures 3 and 4) and
TB patients. In contrast, ESAT-6 induced IL-10 production was
significantly higher in the S2 spouses compared with TB patients
(Figure 3). In addition, the ratio of IFN-c and IL-10 in response to
PPD enhanced the significance of difference between TB contacts
and patients (P,0.01; Figure 4B). IL-17 enhances the Th1
memory response leading to a reduced mycobacterial burden after
BCG vaccination [18] and the lower frequency of IL-17 producing
cells appears to be related to TB progress [19-20]. Recent studies
also demonstrated the potential of IL-17 to distinguish LTBI from
active disease by showing significantly higher frequency of IL-17A
in individuals with LTBI compared with those with active TB
[21]. The results of our study are consistent with these findings; the
median response of IL-17 in response to ESAT-6 was relatively
lower in TB patients compared with ESAT-6 responsive TB
contacts (S2) and the difference in responses between TB patients
and the S2 spouses was emphasised by the ratio of IFN-c/IL-17 in
response to PPD with significantly higher median response in TB
patients than the S2 spouses (P,0.01; Figure 4B).
Harari and colleagues also reported the diagnostic value of
TNF-a for discriminating between latent TB and active disease by
showing a substantial proportion of single positive TNF-a CD4+ T
cells in response to ESAT-6 and CFP-10 in TB patients compared
with the subjects with LTBI [22]. The median level of TNF-a
from Quantiferon supernatants was significantly higher (P = 0.01)
in TB cases than household contacts [4]. In addition, significantly
higher proportions of CD4 T cells producing TNF-a alone or
TNF-a, IFN-c and IL-2 were found in TB cases compared with
contacts [17,23]. In the latter study, TNF-a production in
response to PPD was also significantly higher in TB patients
compared with spouses. Although it was not significantly different
in response to ESAT-6 between TB patients and contacts, TNF-a
production in response to ESAT-6 was higher in the S2 spouses
compared with TB patients, suggesting that the level of TNF-a in
response to ESAT-6 and PPD might be an additional marker for
LTBI to help differentiate them from TB patients as well as
uninfected controls. The IFN-c, CXCL10 and TNF-a in response
to ESAT-6 and PPD did not differentiate between LTBI (S2) and
active TB in our study while significantly differential levels of the
cytokines in addition to sIL2ra and MDC were detected in sera
between active TB patients and individuals with TST+ [24], which
indicates that multiplex analyses using many more cytokines in
serum or culture supernatant would be of great benefit to more
comprehensive biosignature for differential diagnosis of LTBI
versus active TB.
Prior work in Malawi indicates that spouses of smear-positive
pulmonary TB patients have intense contact with infectious TB,
leading to an extremely high risk of infection [6–7]. The spouses in
our study cohort showed a range of TST induration sizes from 0 to
68 mm with the majority of these (26/34) already showing TST
induration of more than 10 mm at baseline. The percentage of
spouses showing TST sizes between 10 and 15 mm was around
38% and declined throughout the follow-up period while the
percentage of those with higher TST size (.15 mm) increased up
to 80% at 24 months follow-up. Only 2 of 101 spouses showed
TST conversion from below 10 mm to above 10 mm with an
increase of more than 6 mm at 6 and 12 months follow-up,
indicative of a conversion. Cytokine responses were compared
between the group of below 10 mm (defined as having a lower risk
of infection) and the group of above 15 mm (defined as having a
higher risk of infection) but there were no significant differences in
cytokine responses depending on the magnitude of the TST
response (data not shown).
Previous work showing a J-shaped relationship between TB
incidence rates and delayed type hypersensitivity responses to
tuberculin indicates that individuals with zero TST induration
may have higher risk of M. tb infection compared with those with
an induration between 5 and 10 mm [25]. Black et al., reported
that 13 of 270 participants with 0 mm of TST induration showed
more than 500 pg/ml of IFN-c responses to PPD, and 7 of 53
individuals with above 10 mm induration showed negative IFN-c
responses (,62.5 pg/ml) in Malawian healthy adolescents without
BCG vaccination [8]. A similar pattern of responses was observed
in the spouses in the current study; 3 of 5 spouses who had 0 mm
of induration showed a high level of IFN-c production to PPD
(.400 pg/mL) and 16 of 91 spouses with more than 10 mm of
TST induration did not produce IFN-c or showed negative
responses.
To identify a biomarker that would predict who would develop
the disease among the latently infected group, ideally we could
study the immune responses in the intensely exposed close TB
contacts (most of whom can be assumed to have latent TB; [6])
and compare responses in those who did not develop TB with
responses in those who showed disease progression during a period
of follow-up. In this study, only samples from HIV negative
spouses were selected for analysis, to avoid the confounding effect
of HIV on the immune response. However, no HIV-negative
spouses had progressed to diseases during the follow up period so
no samples to test for biomarkers predictive of disease progression
were available. Therefore we compared cytokine responses
between TB contacts (segregated based on their IFN-c response
to ESAT-6, since the magnitude of the response may indicate
bacterial load and/or risk of disease [26]) and TB patients (who,
by definition have been unable to control the progress of their
infection). Based on the magnitude of IFN-c response to ESAT-6,
the spouses who have been exposed to TB patients were divided
into two groups; one is considered as a group of exposure with low
possibility of infection (S1; ,62.5 pg/mL) and the other is a group
of exposure with high possibility of infection without active
diseases (S2; .62.5 pg/mL). Therefore, IL-17 and IL-10 detected
in S1 group are considered to be a measure of the exposure
without infection while the cytokines measured in S2 group
indicates a measure of the infection without disease progression.
An IGRA such as QuantiFERON TB GOLD In Tube test has
been developed to diagnose M. tb infection by measuring the
quantitative IFN-c response to M. tb antigens. As the IGRA
includes both ESAT-6 and CFP-10 antigens, we tested IFN-c
responses of TB patients with ESAT-6/CFP-10 stimulation. While
it is possible that using ESAT-6/CFP-10 as the antigen in the
culture assays for TB patients compared to ESAT-6 alone might
have skewed the results, it is unlikely to have a great effect on the
outcome of our analyses based on prior studies which have
repeatedly shown that while ESAT-6 typically stimulates a higher
percentage of responders than CFP10, the nature of the responses
generated is extremely similar. When comparing responses seen to
ESAT-6/CFP10 compared to responses to ESAT-6 alone, we
have rarely seen more than a 3% difference in the magnitude of
the response and have not observed significant differences in the
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type of response evoked. This observation has been confirmed by
other groups showing the detailed comparison where the responses
are strikingly similar [27-29].
In summary, almost all of the intensely-exposed contacts of
smear-positive pulmonary TB patients in this study showed TST
positivity but TST induration size did not correlate with cytokine
responses to ESAT-6 and PPD. CXCL10, IL-17 and TNF-a
production were significantly higher in the group of spouses
thought to have a higher risk of M. tb infection based on higher
ESAT-6 responses. The only single cytokines that distinguished
this group of spouses from TB patients were IL-10 and IL-17. On
the other hand, the ratio of IFN-c/IL-10 and IFN-c/IL-17 in
response to PPD differentiated between TB patients and the S2
group of spouses. In conclusion, IL-17 and IL-10 may improve
diagnosis of LTBI along with the IGRA. Additionally, CXCL10
and TNF-a may also have potential as markers for M. tb infection,
and these findings may contribute to development of more
accurate diagnostics for LTBI.
Supporting Information
Figure S1 The association of the cytokine responses
between transferred and single-use samples (n=56). Five
cytokine ELISAs were carried out with 100 mL of samples and the
samples were transferred from the first to the final ELISA in the
order of IL-13, IL-10 (A), CXCL10 (B), IL-17 (C) and TNF-a (D)
with different volume of samples for each cytokine ELISA. All of
the cytokine responses were strongly correlated between trans-
ferred and single-use samples by Spearman’s rank correlation test
(r.0.9, P,0.001).
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